Bimiralisib Completed Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01940133A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309